1 Glorious Growth Stock Down 81% to Buy on the Dip in January

Core Insights - Docusign has evolved from a leading e-signature technology provider to a comprehensive suite of software tools for managing the entire contract lifecycle, which gained significant traction during the COVID-19 pandemic [1] - The stock reached an all-time high of $310 in late 2021 but has since fallen 81% as conditions normalized [2] - The launch of the Intelligent Agreement Management (IAM) platform, which leverages AI for contract management, is seeing strong demand and may drive a stock recovery [3] Company Developments - IAM addresses inefficiencies in contract management, with Deloitte estimating that businesses lose $2 trillion annually due to these inefficiencies [5] - Key features of IAM include a digital repository called Navigator for easy contract storage and retrieval, and AI-Assisted Review to identify risks and opportunities in contracts [5][6] - As of the end of Docusign's fiscal 2026 third quarter, over 25,000 businesses adopted IAM, marking a 150% increase from six months prior [7] Market Context - Docusign's tools were crucial for businesses to continue operations during the pandemic, but demand decreased as social conditions improved in 2022, leading to a significant drop in stock value [8]